Isolated severe tricuspid regurgitation is associated with larger dimensions of the superior and inferior venae cavae at various levels, a new study shows. What are the implications for transcatheter tricuspid valve intervention?Read More
How Broadly Is Concomitant Tricuspid Repair Indicated as Part of Surgery for Degenerative Mitral Regurgitation?
The jury is still out on whether patients with degenerative mitral regurgitation and less than severe tricuspid regurgitation should undergo tricuspid annuloplasty along with mitral valve surgery.
Valve-Sparing Aortic Root Replacement: Outcomes With Bicuspid Vs. Tricuspid Valves
Outcomes appear to diverge over time between patients with bicuspid versus tricuspid valves, raising concern over the use of bicuspid valve reimplantation in the absence of extensive surgical expertise.
Large Cohort Study of Isolated Tricuspid Regurgitation Yields Novel Risk Score to Guide Care
The study’s resulting risk score predicts mortality outcomes with the aim of providing management guidance. A companion study shows that surgery appears to yield a survival benefit in both primary and secondary TR.
VARC-3: Key Takeaways on Updated Aortic Valve Research Endpoints
The new update to definitions of clinical endpoints for aortic valve disease trials gives more focus to secondary outcomes, composite safety and efficacy measures, and quality-of-life metrics.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Severe Atrial Functional Mitral Regurgitation: Study Presents Most Detailed Profile to Date
An underrecognized form of functional mitral regurgitation of atrial origin demands heightened attention due to higher risks of death and hospitalization for heart failure and lower intervention rates.
New Guidance Available on Rates, Risks and Effects of Post-TAVR Permanent Pacemaker Requirement
A new JACC State-of-the-Art Review recaps the latest on the incidence and predictors of conduction abnormalities following TAVR, as well as their management and subsequent outcomes.
Analysis Reveals Considerable Off-Label Use of Direct Oral Anticoagulants After Heart Valve Replacement
Despite lack of labeling or much safety data, use of DOACs following surgical heart valve replacement is not insignificant — and is growing. So finds a new national cohort study.
5-Year COMMENCE Data Show Continued Promise for Novel Valve Tissue in SAVR
Through five years of follow-up, no cases of valve thrombosis or structural valve deterioration were observed with a bioprosthesis using the new Resilia tissue technology.
Dementia in TAVR Patients Raises Several Risks, But Not Mortality
While baseline cognitive dysfunction entails some risks in patients undergoing TAVR, the procedure is reasonably safe in this setting and may confer potential cognitive and functional benefits. So finds a new cohort study.
Perspectives on the 2020 ACC/AHA Guideline for Valvular Heart Disease: Focus on the Mitral Valve
Three of our valve disease experts reflect on notable changes and developments related to mitral valve disease in the new guideline update.